SCHEMBL3957230

SCHEMBL3957230

O=C1N[C@]2(C(=O)Nc3ccc(F)cc32)C(=O)N1Cc1cc(Cl)nc(Cl)c1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.39
CYP1A2 P05177 1/20 0.36
MAPT P10636 1/20 0.36
CYP2C19 P33261 1/20 0.36
KMT2A Q03164 1/20 0.36
CNR1 P21554 1/20 0.36
BCHE P06276 1/20 0.36
ACHE P22303 1/20 0.36
AKR1B1 P15121 5/20 0.36
EGFR P00533 2/20 0.35
PTGDR2 Q9Y5Y4 3/20 0.35
AKR1A1 P14550 1/20 0.35
CYP2C9 P11712 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
HTR7 P34969 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4169552 0.81 AKR1B1 (0.45) AKR1B1PTGDR2AKR1A1
SCHEMBL3957233 0.78 CYP1A2 (0.39) CYP1A2MAPTCYP2C19KMT2ABCHE
SCHEMBL4976847 0.76 TRAP1 (0.39) ALDH1A1CYP1A2MAPTCYP2C19KMT2A
SCHEMBL4979296 0.75 AKR1B1 (0.41) ALDH1A1CYP1A2MAPTCYP2C19KMT2A
SCHEMBL3950566 0.75 AKR1B1 (0.42) CYP1A2MAPTCYP2C19KMT2ABCHE
SCHEMBL2483991 0.75 CNR1 (0.51) ALDH1A1MAPTCYP2C19KMT2ACNR1
SCHEMBL3954635 0.75 PTGDR2 (0.39) KMT2ACNR1AKR1B1PTGDR2
SCHEMBL2486352 0.74 PTGDR2 (0.62) AKR1B1PTGDR2CYP2C9
SCHEMBL3952571 0.72 OPRL1 (0.43) ALDH1A1CYP1A2MAPTCYP2C19KMT2A
SCHEMBL2484248 0.71 PTGDR2 (0.64) ALDH1A1MAPTKMT2APTGDR2HTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2013216-A2 NOVEL SPIRO [IMIDAZOLIDINE-4, 3' -INDOLE] 2, 2', 5' (1H) TRIONES FOR TREATMENT OF CONDITIONS ASSOCIATED WITH VANILLOID RECEPTOR 1 AstraZeneca AB (SE) 2009-01-14 EP claimed
WO-2007091948-A2 NOVEL SPIRO [IMIDAZOLIDINE-4, 3´-INDOLE] 2, 2´,5´(1H) TRIONES FOR TREATMENT OF CONDITIONS ASSOCIATED WITH VANILLOID RECEPTOR 1 ASTRAZENECA AB (SE) 2007-08-16 WO claimed